Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains.
Rosaria RussoMargherita RomeoTim SchulteMartina MaritanLuca ObertiMaria Monica BarzagoAlberto BarbiroliCarlo PapponeLuigi AnastasiaGiovanni PalladiniLuisa DiomedeStefano RicagnoPublished in: International journal of molecular sciences (2022)
Light chain amyloidosis (AL) is caused by the aberrant overproduction of immunoglobulin light chains (LCs). The resulting abnormally high LC concentrations in blood lead to deposit formation in the heart and other target organs. Organ damage is caused not only by the accumulation of bulky amyloid deposits, but extensive clinical data indicate that circulating soluble LCs also exert cardiotoxic effects. The nematode C. elegans has been validated to recapitulate LC soluble toxicity in vivo, and in such a model a role for copper ions in increasing LC soluble toxicity has been reported. Here, we applied microscale thermophoresis, isothermal calorimetry and thermal melting to demonstrate the specific binding of Cu 2+ to the variable domain of amyloidogenic H7 with a sub-micromolar affinity. Histidine residues present in the LC sequence are not involved in the binding, and yet their mutation to Ala reduces the soluble toxicity of H7. Copper ions bind to and destabilize the variable domains and induce a limited stabilization in this domain. In summary, the data reported here, elucidate the biochemical bases of the Cu 2+ -induced toxicity; moreover, they also show that copper binding is just one of the several biochemical traits contributing to LC soluble in vivo toxicity.
Keyphrases
- oxide nanoparticles
- oxidative stress
- simultaneous determination
- aqueous solution
- heart failure
- electronic health record
- high resolution
- diabetic rats
- gene expression
- genome wide
- solid phase extraction
- dna methylation
- big data
- liquid chromatography
- machine learning
- deep learning
- quantum dots
- multiple myeloma
- water soluble